An attorney representing a man injured by the antipsychotic medication Risperdal painted the drugmaker Johnson & Johnson as a malicious company that pushed for the drug’s off-label use in children despite evidence linking the drug to excessive growth of breast tissue in boys and young men all in an effort to maximize profits over the safety of children.

“They have a target. They know who they want to make money from: kids. And not just any kids. Kids who are the most vulnerable in our society. Kids with autism and Asperger’s and ADD,” Houston lawyer Jason Itkin of Arnold & Itkin told the Philadelphia jury Tuesday morning.